VYNE Therapeutics Reports Private Placement Of $88M
Portfolio Pulse from Benzinga Newsdesk
VYNE Therapeutics is raising $88M through a private placement, selling 10,652,543 shares of its common stock at $2.245 per share and pre-funded warrants to purchase up to 28,614,437 shares at $2.2449 per warrant.
October 30, 2023 | 11:08 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
VYNE Therapeutics is raising capital through a private placement, which could dilute existing shareholders' equity.
The private placement will increase the number of VYNE's outstanding shares, which could dilute the value of existing shares. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100